SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Eye Laser Industry - VISX and Summit BEAM Info
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter Granic who wrote (2)8/6/1996 4:30:00 PM
From: AgAuUSA   of 178
 
Peter,

I do not recall his exact words, however Cohen downgraded BEAM after the stock had fallen substantially. His words were fuel to the fire of many long-term holders who no doubt lost money. Much of the pessimism appears to be associated with a shareholder lawsuit over possibly minor matters.

Warren Buffet's first rule of stock ownership is don't lose money; his second rule is don't forget the first rule.

I personally do not trade on analyst advice. I do my own research. Remember that when either company's laser is sold, both company's share the royalties (via Pillar Point Partners).BEAM has reported excellent results in worldwide trials of its Apex Plus system to treat astigmatism and farsightedness. Currently 150+ Apex systems are in use in the US. Many thousand potential purchasing doctors have received the FDA mandated training program.

My advice is, Just HOLD. I really see all this as a market over-reaction.

Hope this helps,

Greg
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News